Something important happened at the U.S. Patent and Trademark Office (USPTO) last month, and it did not get nearly the attention it deserved.

The terrain of inter partes review (IPR) strategy shifted meaningfully on November 17, 2025. On that date, the USPTO issued a ...

The U.S. Supreme Court on Monday reviewed whether internet service provider Cox Communications should be on the hook for up ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing expected by the end of the year Tessera to receive $150 ...